Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
John Hancock MD

John M. Hancock MD

Clinical Assistant Professor, Hematology/Oncology, McGovern Medical School, University of Texas Health Sciences Center at Houston, Houston, Texas

Dr. J. Matt Hancock originally from Dallas, TX studied Cell and Molecular Biology at the University of Texas at Austin then attended medical school and Internal Medicine residency at the University of Texas Southwestern Medical Center at Dallas. He completed fellowship in Hematology/Oncology at the University of Michigan in Ann Arbor where he studied von Willebrand Factor (VWF) and Thrombotic Thrombocytopenic Purpura (TTP) under David Ginsburg.

Dr. Hancock has clinical interests in bleeding and clotting disorders including von Willebrand Disease, (VWD) Hemophilia and TTP. He is ABIM board certified in Internal Medicine and Hematology and practices at Gulf States Hemophilia and Thrombophilia Center in Houston, Texas. He is a member of the American Society of Hematology, the Hemostasis and Thrombosis Research Society and the International Society of Thrombosis and Hemostasis.